Company / FCF Margin
NewAmsterdam Pharma Co N.V. FCF Margin History
FY2022-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
10.2%
FY2022
5-year range
10.2% / 10.2%
FY2022-FY2022
Trend
-
vs FY2021
Sector context
#42 of 86
Health Care
What the data says
At 10.2%, NewAmsterdam Pharma Co N.V.'s fcf margin ranks #42 of 86 in the Health Care sector.
Based on SEC 10-K filings.
10.2% in FY2022.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#42 of 86 in Health CareTop 49% of 86This company 10.2% Sector average -36.2%
▼
+128.1% above sector average
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.01 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | 10.2% | - |
| FY2021 | - | - |
As of FY2022 · SEC 10-K · Updated Feb 28, 2026